MDT's Quality Score rose 2 points on Wed, Nov 4, to 15. Its 6-month gain rose to 35%, past 30%. 1 more reason, for Pro members.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 11% over the five sessions to Nov 4 while the S&P 500 fell 0.7%.
| Outperforming | Up 34% in 6 months vs the S&P's +1% |
| Its score | Up:Up to Excellent for the first time since Nov 2025 |
| Latest filing | 8-K, Oct 19 |
TodayOn a down day.
After its last 4 reports it closed +2.2% on average, higher 3 of 4 times.
Excellentfor quality, not price, 8 of 14 chart checks firingWhat the Quality Score means
Well above its recent run. MDT scores 15 today, against a median of 10.5 over its last 20 recorded sessions.
MDT is #11 of 85 by Quality Score.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 11 |
Net income over four quarters: MDT $5.23B, BSX $3.67B.
Reports Tue Nov 24, before the open (in 19 days). Confirmed.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
The figures are not read from the release yet.
MDT's results filing gives no sales by line in a table we read.
| Measure | Figure |
|---|---|
| Organic revenue growth | 7.25% to 7.75% |
Sales grew 3.8% a year over 5 years, fiscal 2021 to 2026.
Pays $2.88 a share a year.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Sep 1, 2026 | +3.7% | +1.5% | +1.9% |
| Jun 3, 2026 | +4.6% | +5.7% | +11.2% |
| Feb 17, 2026 | -3.6% | -3.1% | -0.9% |
Sales grew in five of the last seven years, to $36B in 2026. It made a profit in each of the eight years.
Its dividends come to 60% of its free cash flow.
| Dividend | $2.88 a share a year |
| Paid out | About $3.7B a year |
| Free cash flow | $6.1B |
| Record | Raised each of the last 5 years |
One insider sold $476K across 3 filings in the last 6 months. No open-market buys on record. The newest:
27 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: MDT is 1.0% of DGRO, 0.7% of JEPI, and 0.6% of VIG, the most of the 24 funds Breakaway covers, by each fund's latest filing, Jun 30 to Jul 31, 2026.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, surgical robots, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
MDT scores 15 today, which Breakaway calls Excellent. It is #11 of 85 in Medical Devices by Quality Score, with 8 of 14 chart checks firing. Up 11% over the five sessions to Nov 4 while the S&P 500 fell 0.7%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
MDT scores 15 today, which Breakaway calls Excellent (15 to 19). That is #11 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind MDT's 15.
One insider sold $476K across 3 filings in the last 6 months. No open-market buys on record. The newest is Harry Skip Kiil, EVP & President Cardiovascular, who sold $139K on Sep 16. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.